摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Bromo-1-[1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone | 1103424-91-4

中文名称
——
中文别名
——
英文名称
2-Bromo-1-[1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone
英文别名
2-bromo-1-(1-propan-2-ylpyrazol-4-yl)ethanone
2-Bromo-1-[1-(1-methylethyl)-1H-pyrazol-4-yl]ethanone化学式
CAS
1103424-91-4
化学式
C8H11BrN2O
mdl
——
分子量
231.09
InChiKey
QMPLSDOUROSVQS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    34.9
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS<br/>[FR] INHIBITEURS DU RÉCEPTEUR DE FACTEUR-1 DE STIMULATION DE COLONIES (CSF-1R)
    申请人:GENZYME CORP
    公开号:WO2017015267A1
    公开(公告)日:2017-01-26
    Compounds of the formulas I and XIII, which are useful as colony stimulating factor-1 receptor inhibitors ("CSF 1R inhibitors").
    I和XIII式化合物,可用作促细胞增殖因子-1受体抑制剂("CSF 1R抑制剂")。
  • Colony stimulating factor-1 receptor (CSF-1R) inhibitors
    申请人:Genzyme Corporation
    公开号:US11274108B2
    公开(公告)日:2022-03-15
    Compounds of the formulas which are useful as colony stimulating factor-1 receptor inhibitors (“CSF-1R inhibitors”).
    下列式子的化合物 可用作集落刺激因子-1 受体抑制剂("CSF-1R 抑制剂")。
  • COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
    申请人:Genzyme Corporation
    公开号:EP3325471A1
    公开(公告)日:2018-05-30
  • [EN] NOVEL HETEROARYL DERIVATIVES AS ANTAGONISTS OF ADENOSINE A3 RECEPTOR<br/>[FR] NOUVEAUX DÉRIVÉS HÉTÉROARYLE SERVANT D'ANTAGONISTES DU RÉCEPTEUR A3 DE L'ADÉNOSINE
    申请人:ADDEX PHARMACEUTICALS SA
    公开号:WO2009010871A2
    公开(公告)日:2009-01-22
    The present invention relates to novel compounds of Formula (I), wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, M1, M2, M3, Am and Bn are defined as in Formula (I); invention compounds are antagonists of adenosine receptors - subtype 3 (A3) which are useful for the treatment or disorders modulated by A3 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which A3 is involved.
查看更多